Trax Receives $50M Financing
Trax, a Boston, MA-based provider of image recognition solutions for brick-and-mortar retail, raised $50M in financing.
Trax, a Boston, MA-based provider of image recognition solutions for brick-and-mortar retail, raised $50M in financing.
OrbiMed, a global healthcare investment firm, raised more than $4.3 billion in commitments for its latest private investment funds.
Triastek, a Nanjing, China-based company which specializes in 3D printing for pharmaceutical industry, raised USD 20.4M in Pre-C funding.
SuperOrdinary, a Shanghai, New York City, and Los Angeles-based global brand accelerator and expert in establishing and scaling brands in international and domestic channels, closed a $58M Series B funding.
Prins AI, a technology company utilizing advanced AI to create digital identities for enterprises, brands, celebrities, and individuals, closed a $100m Series B financing round.
Hydrexia Holding Limited, a Shanghai, China-based integrated hydrogen technology solution provider, completed its Series D of private equity financing.
Lynk Pharmaceuticals, a Hangzhou, China-based clinical stage company, raised an undisclosed amount in Series C2 funding.
Canton Biologics, a Guangzhou, China-based molecule biopharmaceutical CDMO, raised over 300M Yuan in Series C funding.
BlueRun Ventures China, a Beijing, China-based early-stage technology-focused venture firm, is changing its English brand to Lanchi Ventures.
Grit Biotechnology, a Shanghai, China-based cell therapy company, raised $60M in Series B funding.
Innovac Therapeutics, a Boston, MA-, Shanghai and Hangzhou, China-based mRNA therapeutics company, raised $18M in Series Pre-A funding.
Epigenic Therapeutics, a Shanghai, China-based biotechnology company dedicated to developing gene modulation therapy to treat prevalent diseases, raised $32M in Series A funding.
Neurophth Therapeutics, a Wuhan, China-based gene therapy company for ophthalmic diseases, raised nearly USD95M in Series C+ funding.
Unisun Energy Group, a Shanghai, China-based provider of industrial and commercial intelligent green power services, raised an undisclosed amount in Series C funding.
Atantares, a Beijing, China-based developer of develop molecular chips, closed a Pre-A and Pre-A+ financing all around RMB100m.